Followers | 101 |
Posts | 13186 |
Boards Moderated | 0 |
Alias Born | 06/01/2013 |
Wednesday, October 03, 2018 1:38:53 PM
https://www.bloomberg.com/research/stocks/private/person.asp?personId=43249540&privcapId=25231031
Here is his recommendations
https://www.tipranks.com/analysts/ram-selvaraju
& he gives upside targets
He's in New York City?
https://www.linkedin.com/in/raghuram-selvaraju-phd-mba-ab5a27
https://hcwco.com/services/research/meet-our-analysts/#toggle-id-12
http://www.usaindiachamber.org/Dr-Raghuram-Selvaraju.php
https://www.marketscreener.com/business-leaders/Raghuram-Selvaraju-06G7JN-E/biography/
https://www.terrapinn.com/conference/world-orphan-drug-congress/speaker-raghuram-SELVARAJU.stm
Check out INVO
https://www.streetwisereports.com/pub/htdocs/expert.html?id=7096
He's a Broker
https://brokercheck.finra.org/individual/summary/4978539
Interesting eh
http://www.streetwisereports.com/pub/co/4146#quote
Military HIV Research Program
&
Stanley
University of Pennsylvania
https://www.inovio.com/about#leadership
Something big coming?
HC Wainwright Says Aerpio Pharma Flies Under The Radar Due To OTC Listing, Projects 150% Upside
https://www.benzinga.com/analyst-ratings/analyst-color/18/04/11537292/hc-wainwright-says-aerpio-pharma-flies-under-the-radar-
Let the dreaming continue lol
Inovio's HIV Vaccine Elicits High Response Rates In Phase 1 Trial
https://www.benzinga.com/analyst-ratings/analyst-color/17/05/9520486/inovios-hiv-vaccine-elicits-high-response-rates-in-phase
Now isn't this interesting
PX’Therapeutics And Relief Therapeutics Announce A Strategic Collaboration Agreement For The Recombinant Production Of Atexakin Alfa
RELIEF THERAPEUTICS Holding AG
Dr. Raghuram Selvaraju
Investor Relations
https://www.biospace.com/article/releases/px-therapeutics-and-relief-therapeutics-announce-a-strategic-collaboration-agreement-for-the-recombinant-production-of-atexakin-alfa-/
Well, whada ya know
https://relieftherapeutics.com/board-of-directors/
later Bro
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM